logo conference-reports

Conference Reports

При финансовой поддержке logo MSD Oncology

WCGI 2018 - mFOLFIRINOX vs Gemcitabine for resected non-metastatic pancreatic cancer

mFOLFIRINOX new standard of care in resected non-metastatic pancreatic cancer (nmPC)